secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0001437749-21-024453
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife reports Q3 operating loss of $0.8M; revenue down 11% to $21.8M
------------------------------------------------------------------------

- Net loss $0.6M ($0.04/diluted share); adjusted EPS unfavorably impacted by $0.08 from supply chain delays.
- Revenue $21.8M, down 10.7% YoY; commercial sales up 5%, government/defense sales down 40%.
- Delayed shipments from supply chain bottlenecks adversely impacted revenue by ~$4.1M in Q3.
- Backlog increased ~22% sequentially; cash $15.9M, up 49% from year-end 2020; debt reduced to $0.3M.
- Battery & Energy revenue down 8% to $20.0M; Communications Systems down 31% to $1.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774921024453/0001437749-21-024453-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774921024453/ulbi20211027_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-024453

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer